购物车
- 全部删除
- 您的购物车当前为空
MS21570 作为 GPR171 拮抗剂基于其阻断能力,IC50 为 220 nM,可减少小鼠的焦虑样行为和恐惧条件反射。
为众多的药物研发团队赋能,
让新药发现更简单!
MS21570 作为 GPR171 拮抗剂基于其阻断能力,IC50 为 220 nM,可减少小鼠的焦虑样行为和恐惧条件反射。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 198 | 现货 | |
5 mg | ¥ 463 | 现货 | |
10 mg | ¥ 747 | 现货 | |
25 mg | ¥ 1,330 | 现货 | |
50 mg | ¥ 2,230 | 现货 | |
100 mg | ¥ 3,820 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 822 | 现货 |
产品描述 | MS21570 as a GPR171 antagonist based on its ability to block,with an IC50 of 220 Nm,that reduces anxiety-like behavior and fear conditioning in mice. |
靶点活性 | GPR171:220 nM |
体内活性 | GPR171在焦虑样行为或恐惧条件反射中的作用,通过系统性或BLA内部注射MS21570,以及通过BLA中GPR171的慢病毒介导的敲除来评估。系统性注射MS21570可减轻焦虑样行为,而BLA内部注射或BLA中GPR171的敲除则能减少焦虑样行为和恐惧条件反射。 |
动物实验 | Mice were habituated to the testing room 1?h prior to each experiment.?Behaviors were videotaped and analyzed using Noldus EthoVision XT or by an experimenter blinded to the treatment groups.?Mice were injected with MS21570 (5?mg/kg) 15?min prior to elevated plus maze, open field, forced swim, and contextual fear conditioning.?For microinjection studies, MS21570 was injected 10?min prior to testing and immediately following the contextual fear conditioning.?A counterbalanced within-subjects design was used when appropriate (battery of anxiety tests). |
别名 | 5-(苄基硫代)-N-甲基-1,3,4-噻二唑-2-胺 |
分子量 | 237.34 |
分子式 | C10H11N3S2 |
CAS No. | 65373-29-7 |
Smiles | CNc1nnc(SCc2ccccc2)s1 |
密度 | 1.31 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 125 mg/mL (526.67 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容